Published On:December 14 2023
Story Viewed 854 Times

German Firm TÜV SÜD Invests €15 Million in Bengaluru Lab Test Facility

Germany-based safety and sustainability solutions provider, TÜV SÜD, has invested 15 million euros (approximately Rs. 134.8 crore) in its newly constructed laboratory and testing facility in Bengaluru. This strategic move is fueled by the company's expansion plans in India and aligns with the government's 'Make-in-India' initiative.

Marking its second lab facility in Bengaluru, following the inauguration of the Food Analytical, Chemical & Microbiology laboratory in 2005 at the Peenya Industrial Estate, TÜV SÜD is reinforcing its presence in India. The company already operates a network of over 39 offices and testing facilities across Bengaluru, Gurugram, Mumbai, Tiruppur, and Visakhapatnam.

TÜV SÜD, boasting a global workforce of over 30,000 employees, has 2,500 employees in India. The company reported revenues of Rs. 500 crore in India this year alone. The newly established facility covers 3 acres and includes 70,000 square feet in its initial phase, designed to accommodate approximately 200 staff. The facility is equipped with the latest technology and sustainable building materials, emphasizing energy efficiency and employee well-being.

Ishan Palit, Chief Operating Officer and Member of the Board at TÜV SÜD, emphasized the company's commitment to India's growing economy and middle-class population. He stated, "This state-of-the-art facility and our future investments will further strengthen our role as a key enabler to assist manufacturers to serve the world and the country with products embedded with quality, safety, security, and sustainability."

TÜV SÜD's investment in India aims to support the expansion of the company's footprint in electrical safety, electromagnetic compatibility, and medical device testing and certification services. The facility is strategically designed for growth in electrical components and medical devices, anticipating a 14-15% compound annual growth rate by the end of 2024. The company sees substantial potential in India's medical device industry and is poised to play a crucial role in supporting its growth and development.

BS





OUR OTHER PRODUCTS & SERVICES: Projects Database | Tenders Database | About Us | Contact Us | Terms of Use | Advertise with Us | Privacy Policy | Disclaimer | Feedback

This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2026

Technology Partner - Pairscript Software